Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 75/100

ResMed Announces Participation in the RBCCM Global Healthcare Conference

Key Takeaway: ResMed (NYSE: RMD) will be represented by Dr. Carlos Nunez and Amy Wakeham during a fireside chat at the 2024 RBCCM Global Healthcare Conference on May 14, 2024. The event aims to discuss ResMed's innovative healthcare solutions and technologies for managing chronic diseases such as sleep apnea and COPD. Interested parties can access the live webcast and subsequent replay through ResMed's investor relations platform.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference indicates the company's active presence in the industry.
  • The engagement will feature key executives, enhancing investor visibility.
  • ResMed continues to promote its innovative healthcare solutions for chronic diseases, showcasing its commitment to improving patient care.

Full Press Release Details

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, beginning at approximately 4:05 p.m. (Eastern Daylight Time) at the InterContinental New York Barclay, in New York, NY.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When will ResMed's fireside chat take place?

The fireside chat will occur on May 14, 2024, at about 4:05 p.m. EDT.

Who will speak at the RBCCM Global Healthcare Conference?

Dr. Carlos Nunez and Amy Wakeham will speak at the conference.

How can I access the live webcast of the event?

You can access the live webcast on ResMed's investor website.

How soon is the audio replay available after the chat?

The audio replay will be available about 24 hours after the event.

What does ResMed specialize in?

ResMed specializes in solutions for sleep apnea, COPD, and chronic diseases.

Last updated: May 7, 2024